A BioPharma Leader
Bristol-Myers Squibb is a global BioPharma company firmly
focused on its Mission to discover,
develop and deliver innovative medicines that help patients prevail over serious
Around the world, our medicines help millions of people in their fight
against such diseases as cancer, cardiovascular disease, hepatitis C, HIV/AIDS
and rheumatoid arthritis.
At Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach
and resources of a major pharma company with the entrepreneurial spirit and
agility of a successful biotech company. With this strategy, we focus on our
customers’ needs, giving maximum priority to accelerating pipeline development,
delivering sales growth and continuing to manage costs.
The strategy is working. In recent years our total return for
shareholders, including dividends, has been among the best in the
industry. We outperformed most mega pharma companies, diversified companies and
pure biotech companies. Reflecting our long-standing commitment to deliver
shareholder value, our company has paid dividends to stockholders for more than
300 consecutive quarters.
We have delivered 12 new
medicines to patients in the past 7 years.
organization is considered among the most productive in the industry. And the
String of Pearls strategy of innovative alliances, partnerships and acquisitions
further enhances our internal capabilities. Our full array of pearls encompasses
many of our key disease areas, including cancer, cardiovascular disease,
immunology, neuroscience and virology.
Pursuing our Mission also means we are working to provide patient access to
health care. We are striving to that goal through public/private partnerships
SECURE THE FUTURE, our groundbreaking $150 million program to
help confront HIV/AIDS in Africa. In addition, through our
patient assistance programs, we provide free medications to
qualifying patients with financial hardship in the U.S.
Innovation is critical for successfully executing our BioPharma strategy.
That innovation is enhanced by a
diverse workforce and an inclusive culture. Bristol-Myers Squibb has
been recognized year after year as one of the best companies for female
executives and working mothers. We’ve also been recognized by the Human Rights
Campaign Foundation’s Corporate Equality Index for achieving a perfect score for
four consecutive years.
Preservation of our
natural resources also represents one of our key commitments. At many
of our facilities worldwide, our company is integrating comprehensive energy
management, pollution controls and other practices to reduce environmental
impacts. Bristol-Myers Squibb is recognized among the leading
Ultimately, our success as a BioPharma leader is measured by the difference
we make in the lives of patients.